Haemonetics Operating Income 2011-2025 | HAE
Haemonetics operating income from 2011 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Haemonetics Annual Operating Income (Millions of US $) |
|
|---|---|
| 2025 | $222 |
| 2024 | $165 |
| 2023 | $156 |
| 2022 | $81 |
| 2021 | $90 |
| 2020 | $103 |
| 2019 | $84 |
| 2018 | $56 |
| 2017 | $-19 |
| 2016 | $-44 |
| 2015 | $41 |
| 2014 | $46 |
| 2013 | $56 |
| 2012 | $89 |
| 2011 | $111 |
|
Haemonetics Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $58 |
| 2025-06-30 | $54 |
| 2025-03-31 | $71 |
| 2024-12-31 | $59 |
| 2024-09-30 | $52 |
| 2024-06-30 | $40 |
| 2024-03-31 | $30 |
| 2023-12-31 | $46 |
| 2023-09-30 | $35 |
| 2023-06-30 | $54 |
| 2023-03-31 | $35 |
| 2022-12-31 | $43 |
| 2022-09-30 | $47 |
| 2022-06-30 | $31 |
| 2022-03-31 | $19 |
| 2021-12-31 | $36 |
| 2021-09-30 | $25 |
| 2021-06-30 | $1 |
| 2021-03-31 | $-21 |
| 2020-12-31 | $40 |
| 2020-09-30 | $59 |
| 2020-06-30 | $12 |
| 2020-03-31 | $26 |
| 2019-12-31 | $41 |
| 2019-09-30 | $50 |
| 2019-06-30 | $-13 |
| 2019-03-31 | $24 |
| 2018-12-31 | $28 |
| 2018-09-30 | $26 |
| 2018-06-30 | $5 |
| 2018-03-31 | $14 |
| 2017-12-31 | $1 |
| 2017-09-30 | $24 |
| 2017-06-30 | $17 |
| 2017-03-31 | $-58 |
| 2016-12-31 | $21 |
| 2016-09-30 | $25 |
| 2016-06-30 | $-8 |
| 2016-03-31 | $-6 |
| 2015-12-31 | $-61 |
| 2015-09-30 | $19 |
| 2015-06-30 | $4 |
| 2015-03-31 | $12 |
| 2014-12-31 | $18 |
| 2014-09-30 | $12 |
| 2014-06-30 | $-2 |
| 2014-03-31 | $12 |
| 2013-12-31 | $18 |
| 2013-09-30 | $23 |
| 2013-06-30 | $-7 |
| 2013-03-31 | $18 |
| 2012-12-31 | $16 |
| 2012-09-30 | $10 |
| 2012-06-30 | $13 |
| 2012-03-31 | $21 |
| 2011-12-31 | $25 |
| 2011-09-30 | $19 |
| 2011-06-30 | $24 |
| 2011-03-31 | $29 |
| 2010-12-31 | $29 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.479B | $1.361B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $226.106B | 26.06 |
| EssilorLuxottica (ESLOY) | France | $168.548B | 0.00 |
| Boston Scientific (BSX) | United States | $150.853B | 34.49 |
| Stryker (SYK) | United States | $137.722B | 27.34 |
| Medtronic (MDT) | Ireland | $123.497B | 17.41 |
| Lonza Group Ag (LZAGY) | Switzerland | $47.264B | 0.00 |
| Agilent Technologies (A) | United States | $40.971B | 26.52 |
| ResMed (RMD) | United States | $35.713B | 24.72 |
| GE HealthCare Technologies (GEHC) | United States | $32.173B | 15.39 |
| Koninklijke Philips (PHG) | Netherlands | $26.943B | 17.60 |
| Insulet (PODD) | United States | $23.075B | 71.62 |
| Terumo (TRUMY) | Japan | $22.623B | 25.47 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.567B | 10.96 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.901B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.361B | 0.00 |
| Baxter (BAX) | United States | $9.135B | 7.37 |
| Bio-Rad Laboratories (BIO) | United States | $8.202B | 29.49 |
| Demant (WILYY) | Denmark | $7.346B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.481B | 10.61 |
| ICU Medical (ICUI) | United States | $3.321B | 21.08 |
| Envista Holdings (NVST) | United States | $3.142B | 18.03 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.836B | 12.93 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| Perrigo (PRGO) | Ireland | $1.866B | 4.68 |
| Phibro Animal Health (PAHC) | United States | $1.826B | 18.24 |
| AtriCure (ATRC) | United States | $1.647B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.433B | 9.21 |
| Neogen (NEOG) | United States | $1.395B | 26.75 |
| Curaleaf Holdings (CURLF) | Canada | $1.345B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.291B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 18.29 |
| Green Thumb Industries (GTBIF) | United States | $1.186B | 52.00 |
| Tilray Brands (TLRY) | Canada | $1.157B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.156B | 343.00 |
| InMode (INMD) | Israel | $0.879B | 9.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.854B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| Omeros (OMER) | United States | $0.644B | 0.00 |
| Surmodics (SRDX) | United States | $0.612B | 0.00 |
| CeriBell (CBLL) | United States | $0.478B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.474B | 16.33 |
| Evolus (EOLS) | United States | $0.451B | 0.00 |
| SNDL (SNDL) | Canada | $0.439B | 0.00 |
| BillionToOne (BLLN) | $0.417B | 0.00 | |
| Cresco Labs (CRLBF) | United States | $0.319B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.297B | 50.60 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.280B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.260B | 0.00 |
| Quanterix (QTRX) | United States | $0.258B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.252B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.244B | 143.33 |
| Viemed Healthcare (VMD) | United States | $0.239B | 19.06 |
| High Tide (HITI) | Canada | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.224B | 2.24 |
| TriSalus Life Sciences (TLSI) | United States | $0.223B | 0.00 |
| Organigram Global (OGI) | Canada | $0.201B | 0.00 |
| Exagen (XGN) | United States | $0.192B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 15.52 |
| FitLife Brands (FTLF) | United States | $0.165B | 20.35 |
| OraSure Technologies (OSUR) | United States | $0.161B | 0.00 |
| Apyx Medical (APYX) | United States | $0.154B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.146B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.133B | 0.00 |
| Biote (BTMD) | United States | $0.118B | 5.16 |
| Quipt Home Medical (QIPT) | United States | $0.098B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.089B | 12.96 |
| Sharps Technology (STSS) | United States | $0.081B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| Nephros (NEPH) | United States | $0.058B | 41.77 |
| ImmuCell (ICCC) | United States | $0.044B | 18.89 |
| Jin Medical (ZJYL) | China | $0.044B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.041B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Modular Medical (MODD) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.19 |
| Bonk (BNKK) | United States | $0.024B | 0.00 |
| Zynex (ZYXI) | United States | $0.017B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Functional Brands (MEHA) | $0.003B | 0.00 | |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |